This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Osmozis Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Osmozis has a total shareholder equity of €15.7M and total debt of €14.1M, which brings its debt-to-equity ratio to 90%. Its total assets and total liabilities are €34.0M and €18.3M respectively. Osmozis's EBIT is €1.6M making its interest coverage ratio 4.4. It has cash and short-term investments of €10.6M.

Belangrijke informatie

90.0%

Verhouding schuld/eigen vermogen

€14.11m

Schuld

Rente dekkingsratio4.4x
Contant€10.64m
Aandelen€15.68m
Totaal verplichtingen€18.35m
Totaal activa€34.03m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 9VL's short term assets (€16.5M) exceed its short term liabilities (€6.3M).

Langlopende schulden: 9VL's short term assets (€16.5M) exceed its long term liabilities (€12.1M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 9VL's net debt to equity ratio (22.1%) is considered satisfactory.

Schuld verminderen: 9VL's debt to equity ratio has reduced from 117.4% to 90% over the past 5 years.

Schuldendekking: 9VL's debt is well covered by operating cash flow (28.5%).

Rentedekking: 9VL's interest payments on its debt are well covered by EBIT (4.4x coverage).


Balans


Ontdek gezonde bedrijven